Epigenica
Latest round
- Seed
Last raised
- Jun 2025
Total raised
- $2.3M
Investors
- 4
About Epigenica
Epigenica AB is a Swedish biotechnology firm founded in 2020, headquartered in Solna, Sweden. The company focuses on epigenetic analysis, with its flagship product, the EpiFinder™ platform, allowing concurrently high-throughput analysis of DNA methylation and histone modifications.Epigenica specializes in innovative solutions for epigenetic analysis, primarily focusing on their flagship product, the EpiFinder™ platform. This advanced multiplexed ChIP-seq technology allows researchers to conduct high-throughput analysis of both DNA methylation (DNAm) and histone post-translational modifications (HPTMs) simultaneously, a significant advancement over existing technologies that typically restrict profiling to one type at a time. The EpiFinder™ Genome kit enables comprehensive genome-wide profiling, allowing scientists to target up to eight epigenetic markers across 24 samples or replicates, generating a total of 192 quantitative ChIP-seq tracks from only 125,000 cells per track.Epigenica operates on a transaction model primarily structured around direct sales of their EpiFinder™ product line, which includes the EpiFinder™ Genome kit and upcoming offerings such as EpiFinder™ Global and EpiFinder™ cNUC. The company engages with clients in the biotechnology and pharmaceutical sectors, offering bespoke solutions tailored for high-throughput epigenetic research. Transactions are executed through one-time purchases, where customers acquire kits that include necessary reagents and protocols for generating sequencing-ready libraries. The pricing structure reflects their innovative capabilities and the advanced technology incorporated, designed to facilitate advancements in research efficiency and data quality. Upcoming products include EpiFinder™ Global and EpiFinder™ cNUC, which are expected to enhance their offerings. The expansion into the US market is a strategic move aimed at increasing their global footprint and addressing the demands of a larger client base.
Who invested in Epigenica
4 investors across 1 round
See all investors in Epigenica
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 19, 2025
Amount
$2.3M
Investors
Questions about Epigenica
Who invested in Epigenica?
Epigenica has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Epigenica raised?
Epigenica has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Epigenica last raise money?
Epigenica's most recent round on record is a Seed, in Jun 2025.
What does Epigenica do?
Epigenica AB is a Swedish biotechnology firm founded in 2020, headquartered in Solna, Sweden.
Where is Epigenica headquartered?
Epigenica is headquartered in Solna, Sweden.
Which VCs invest in companies like Epigenica?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Epigenica's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Epigenica? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.